• Loading stock data…

Concentric Analgesics Announces Completion of $20 Million Financing and Appoints Two New Board Members as it Prepares to Initiate Registration-Enabling Phase 3 Studies for Vocacapsaicin

[#item_full_content]

Print Friendly, PDF & Email
Spread the word